Analysis of MLH1, MSH2 and CAS 20q13 mutations in platinum refractory patients with the ovarian cancer
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | V. G. Dubinina, A. I. Rybin, M. A. Lysenko, O. V. Kuznetsova |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Actual problems of transport medicine: environment, occupational health, pathology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000571964 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Novel germline MLH1 and MSH2 mutations in latvian Lynch syndrome families
by: Berzina, D., et al.
Published: (2012)
by: Berzina, D., et al.
Published: (2012)
Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
by: A. I. Rybin, et al.
Published: (2018)
by: A. I. Rybin, et al.
Published: (2018)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
Survivin expression in ovarian cancer
by: Liguang, Z., et al.
Published: (2007)
by: Liguang, Z., et al.
Published: (2007)
Molecular-biological features of ovarian cancer patients with aggregation of cancer in pedigrees
by: I. P. Nesina, et al.
Published: (2017)
by: I. P. Nesina, et al.
Published: (2017)
Experience of diagnostic laparoscopy use in patients with advanced ovarian cancer
by: O. A. Mikhanovskyi, et al.
Published: (2019)
by: O. A. Mikhanovskyi, et al.
Published: (2019)
Contemporary views on the etiology and pathogenesis of ovarian cancer
by: T. V. Bazarinskaja
Published: (2018)
by: T. V. Bazarinskaja
Published: (2018)
Evaluation of serum adenosine deaminase and its isoenzymes in patients with ovarian cancer
by: A. Asadi, et al.
Published: (2018)
by: A. Asadi, et al.
Published: (2018)
Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
by: A. A. Mikhanovskij, et al.
Published: (2014)
by: A. A. Mikhanovskij, et al.
Published: (2014)
Heterocoagulation of platinum nanoparticles modified by polysaccharides and functionalized by pholates with cancer cells
by: V. R. Estrela-Lopis, et al.
Published: (2013)
by: V. R. Estrela-Lopis, et al.
Published: (2013)
Current recommendations for the diagnosis and treatment of epithelial ovarian cancer
by: V. S. Svintsitskyi, et al.
Published: (2019)
by: V. S. Svintsitskyi, et al.
Published: (2019)
Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
by: K. H. Baumann, et al.
Published: (2013)
by: K. H. Baumann, et al.
Published: (2013)
Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
by: Baumann, K.H., et al.
Published: (2013)
by: Baumann, K.H., et al.
Published: (2013)
Auditing the Functional Part of the CAS Software
by: O. V. Adamyk, et al.
Published: (2017)
by: O. V. Adamyk, et al.
Published: (2017)
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: A. A. Stepanenko, et al.
Published: (2012)
by: A. A. Stepanenko, et al.
Published: (2012)
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
by: Stepanenko, A.A., et al.
Published: (2012)
by: Stepanenko, A.A., et al.
Published: (2012)
Electron beam refining in production of platinum and platinum-base alloys. Information 1. Electron beam refining of platinum
by: Savenko, V.A., et al.
Published: (2008)
by: Savenko, V.A., et al.
Published: (2008)
Ways of improving the results of treatment of advanced forms of ovarian cancer
by: A. A. Mikhanovskij, et al.
Published: (2015)
by: A. A. Mikhanovskij, et al.
Published: (2015)
Manifestations of oxidative stress and molecular damages in ovarian cancer tissue
by: H. I. Falfushynska, et al.
Published: (2015)
by: H. I. Falfushynska, et al.
Published: (2015)
Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine
by: B. T. Klimuk, et al.
Published: (2017)
by: B. T. Klimuk, et al.
Published: (2017)
Mobile genetic elements and cancer. From mutations to gene therapy
by: Kozeretska, I.A., et al.
Published: (2011)
by: Kozeretska, I.A., et al.
Published: (2011)
Individual prognosis of serous ovarian cancer survival patients based on adhesion and proliferation of tumor cells
by: O. D. Ryabtseva, et al.
Published: (2014)
by: O. D. Ryabtseva, et al.
Published: (2014)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: O. D. Ryabtseva, et al.
Published: (2013)
by: O. D. Ryabtseva, et al.
Published: (2013)
Biomolecular markers as factors of prognosis of stage 3-4 ovarian cancer
by: A. A. Mikhanovskij, et al.
Published: (2016)
by: A. A. Mikhanovskij, et al.
Published: (2016)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: Ryabtseva, O.D., et al.
Published: (2013)
by: Ryabtseva, O.D., et al.
Published: (2013)
Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer
by: Zelinskaya, A.
Published: (2023)
by: Zelinskaya, A.
Published: (2023)
FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients
by: M. P. Smal, et al.
Published: (2014)
by: M. P. Smal, et al.
Published: (2014)
FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients
by: Smal, M.P., et al.
Published: (2014)
by: Smal, M.P., et al.
Published: (2014)
CRISPR/Cas9 technology for targeted genome editing
by: N. A. Lomov, et al.
Published: (2015)
by: N. A. Lomov, et al.
Published: (2015)
Rhenium–platinum antitumor systems
by: A. V. Shtemenko, et al.
Published: (2017)
by: A. V. Shtemenko, et al.
Published: (2017)
Kinetic of wetting of zirconia by platinum
by: A. V. Durov, et al.
Published: (2012)
by: A. V. Durov, et al.
Published: (2012)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
Meiotic segregation of chromosomes 13 and 14 in sperm of heterozygous robertsonian translocation der(13;14) (q10; q10)
by: Ja. Pilip, et al.
Published: (2014)
by: Ja. Pilip, et al.
Published: (2014)
FGFR3 R249C (742 C>T) mutation in patients with bladder cancer
by: Ya. M. Mishchuk, et al.
Published: (2016)
by: Ya. M. Mishchuk, et al.
Published: (2016)
The JAK2 V617F mutation in lung cancer: caveat emptor
by: Langabeer, S.E.
Published: (2018)
by: Langabeer, S.E.
Published: (2018)
Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
by: Ye. V. Horodetska, et al.
Published: (2018)
by: Ye. V. Horodetska, et al.
Published: (2018)
Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)
by: Zakhartseva, L.M., et al.
Published: (2009)
Biological features of serous ovarian cancer with regard to the r53 expression and its modulators
by: I. P. Nesina, et al.
Published: (2015)
by: I. P. Nesina, et al.
Published: (2015)
Investigation of the effect of refractory particles in slag on adhesion to refractories
by: E. N. Sigarev, et al.
Published: (2018)
by: E. N. Sigarev, et al.
Published: (2018)
Androgen deprivation therapy in combination with chemotherapy in patients with castrate-naive metastatic prostate cancer
by: A. N. Dubinina
Published: (2016)
by: A. N. Dubinina
Published: (2016)
Similar Items
-
Novel germline MLH1 and MSH2 mutations in latvian Lynch syndrome families
by: Berzina, D., et al.
Published: (2012) -
Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
by: A. I. Rybin, et al.
Published: (2018) -
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016) -
Survivin expression in ovarian cancer
by: Liguang, Z., et al.
Published: (2007) -
Molecular-biological features of ovarian cancer patients with aggregation of cancer in pedigrees
by: I. P. Nesina, et al.
Published: (2017)